Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-11-15
2005-11-15
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252160, C514S257000, C544S115000, C544S246000
Reexamination Certificate
active
06964960
ABSTRACT:
The invention provides compounds of formula (I) wherein R is as defined in the description, and the preparation thereof. The compounds of formula (I) are useful as pharmaceuticals, for use in the treatment of any state associated with high levels of activeted PARP.
REFERENCES:
patent: 5441955 (1995-08-01), Baker et al.
patent: 1309 485 (1973-03-01), None
patent: 1 428 488 (1976-03-01), None
patent: WO 95 24379 (1995-09-01), None
Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabo C, Endres M., Int J Mol Med. Mar. 2001;7(3):255-60, Medline Abstract PMID: 11179503.
Alexander Bürkle, BioEssays vol. 23, Issue 9, pp. 795-806.
Portmann Robert
Rigel Dean Franklin
Zimmermann Kaspar
McKenzie Thomas C.
Novartis AG
Wilusz, Jr. E. Jay
LandOfFree
Indoloquinazolinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indoloquinazolinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoloquinazolinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3511693